Dementia in Older Men Not Prevented By Vitamin E, Selenium

Share this content:
There is no observable reduction in the incidence of dementia with supplements of vitamin E, selenium, or both.
There is no observable reduction in the incidence of dementia with supplements of vitamin E, selenium, or both.

HealthDay News — Neither vitamin E, selenium, nor the combination prevents dementia in asymptomatic older men, according to a study published online in JAMA Neurology.

Richard J. Kryscio, PhD, from the University of Kentucky in Lexington, and colleagues examined whether antioxidant supplements used alone or in combination could prevent dementia in asymptomatic older men. A total of 7540 older men were recruited into the Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADViSE) randomized clinical trial; 3786 of these men continued into a cohort study. Participants were randomized to vitamin E, selenium, vitamin E and selenium, or placebo, and were assessed for dementia while taking study supplements.

The researchers found that the incidence of dementia (4.4 percent) was not different among the 4 study arms. Compared with placebo, the hazard ratios were 0.88 (95 percent confidence interval, 0.64 to 1.20) for vitamin E, 0.83 (95 percent confidence interval, 0.60 to 1.13) for selenium, and 1.00 (95 percent confidence interval, 0.75 to 1.35) for the combination, after adjustment for participant demographic information and baseline self-reported comorbidities.

"Neither supplement prevented dementia," the authors write. "To our knowledge, this is the first study to investigate the long-term association of antioxidant supplement use and dementia incidence among asymptomatic men."

Several authors disclosed financial ties to the pharmaceutical industry.

Reference

Kryscio RJ, Erin L. Abner el, Caban-Holt, A, et al. Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE) [published online March 20, 2017]. JAMA Neurol. doi:10.1001/jamaneurol.2016.5778

You must be a registered member of Psychiatry Advisor to post a comment.

Sign Up for Free e-newsletters